Medpace Holdings, Inc. (MEDP) Debt / Equity
- 2018-12-31: Debt/Equity Ratio 0.13.
- 2018-09-30: Debt/Equity Ratio 0.2.
- 2018-06-30: Debt/Equity Ratio 0.3.
- 2018-03-31: Debt/Equity Ratio 0.38.
Complete source-backed debt/equity ratio history.
- Available history
- 2015-12-31 to 2018-12-31
- Data captured
Historical Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2018-12-31 | 0.13 |
| 2018-09-30 | 0.2 |
| 2018-06-30 | 0.3 |
| 2018-03-31 | 0.38 |
| 2017-12-31 | 0.44 |
| 2017-09-30 | 0.34 |
| 2017-06-30 | 0.26 |
| 2017-03-31 | 0.26 |
| 2016-12-31 | 0.27 |
| 2016-09-30 | 0.25 |
| 2015-12-31 | 0.91 |
Annual Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2018-12-31 | 0.13 |
| 2017-12-31 | 0.44 |
| 2016-12-31 | 0.27 |
| 2015-12-31 | 0.91 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |